BATM Advanced Communications Ltd.

Tel Aviv Stock Exchange BVC.TA

BATM Advanced Communications Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -6.12 M

BATM Advanced Communications Ltd. Net Cash Used For Investing Activities is USD -6.12 M for the year ending December 31, 2023, a 62.55% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • BATM Advanced Communications Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -16.34 M, a -208.45% change year over year.
  • BATM Advanced Communications Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 15.07 M, a 374.93% change year over year.
  • BATM Advanced Communications Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -5.48 M, a -112.28% change year over year.
  • BATM Advanced Communications Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -2.58 M, a -408.85% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
SV Wall Street
Tel Aviv Stock Exchange: BVC.TA

BATM Advanced Communications Ltd.

CEO Mr. Moti Nagar CPA
IPO Date Feb. 27, 2019
Location Israel
Headquarters Neve Ne’eman Ind. Area
Employees 980
Sector Healthcare
Industries
Biotechnology 3D Printing Defense & Military Hardware & Electronics Medical Instruments Plastics Robotics Telehealth
Description

BATM Advanced Communications Ltd., together with its subsidiaries, develops, produces, and markets real-time technologies in Israel, the United States, and Europe. It operates through two segments, Networking and Cyber, and Bio-Medical. The Networking and Cyber segment is involved in the research and development, production, and marketing of data communication products, including network function virtualization, edge computing, carrier ethernet and MPLS access solutions, cyber network monitoring, and network encryption. This segment also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical segment offers molecular biology diagnostics; and solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications. This segment also administers testing services; and distributes diagnostic equipment and medical supplies of various brands. The company was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email